GLOW (Multi-Peptide Complex)

The Glow Protocol Peptide Blend is an advanced synergistic formulation consisting of  GHK-Cu, TB-500, and BPC-157, designed to enhance regenerative processes and support systemic recovery in non-human test subjects within controlled laboratory environments.

• GHK-Cu, a copper-binding peptide.
• TB-500, a synthetic variant of thymosin beta-4.
• BPC-157, is a synthetic peptide studied for its regenerative effects in non-human lab subjects.

This blend is designed for high-throughput studies focused on optimising tissue regeneration, wound healing, and metabolic regulation in non-human test subjects. The combination of these peptides holds the potential to advance the understanding of recovery and repair mechanisms in research lab test subjects.

Glow 70mg Peptide Blend consists of: 

GHK-Cu: 50 mg

BPC-157: 10 mg

TB-500 (Thymosin Beta-4 fragment): 10 mg

GLOW combines three extensively studied peptides into one streamlined formulation, enabling broader regenerative pathway research without the need for separate compounds.

Its multi-target design allows researchers to explore both localized and systemic recovery responses within a single protocol, making it well suited for advanced regenerative and metabolic research applications.

This blend is designed for high-throughput studies focused on optimising tissue regeneration, wound healing, and metabolic regulation in non-human test subjects. The combination of these peptides holds the potential to advance the understanding of recovery and repair mechanisms in research lab test subjects.